55岁及以下与56岁及以上患者单髁膝关节置换术后至少10年随访的功能结局评分与假体生存率无差异
本研究比较55岁及以下与56岁及以上接受单髁膝关节置换术(UKA)患者的结局。经倾向性评分匹配后每组各71例,至少随访10年(平均13年),结果显示两组在牛津膝关节评分、膝关节协会评分、SF-36躯体与心理组分及无全因翻修生存率上均无显著差异。作者认为经适当选择的年轻患者不应被排除在UKA潜在获益之外。
要点
- 匹配后每组71例,至少随访10年,平均随访13年。
- 10年时OKS、膝关节协会评分、SF-36躯体与心理组分两组均无显著差异。
- 两组10年无全因翻修生存率均为0.96(95%CI,0.91-1.00)。
核心结论
- 作者认为,由于55岁及以下与56岁及以上患者UKA术后功能结局、生活质量和假体生存率差异很小,经适当选择的年轻患者不应被排除在UKA潜在获益之外,尤其是在高手术量术者手中。
研究设计与样本
- 2004年至2007年在一家机构接受UKA的患者中,55岁及以下100例中3例(3%)死亡、13例(13%)在10年最低随访前失访,余84例可供倾向性评分匹配;56岁及以上343例中48例(14%)死亡、59例(17%)在10年前失访,余236例可供潜在纳入。
- 经倾向性评分匹配校正术前混杂变量(术者、患者体重指数和性别)后按年龄分为55岁及以下组与56岁及以上组,每组各71例,最低随访10年。
- 55岁及以下组平均年龄52岁(范围45-55岁),56岁及以上组平均年龄64岁(范围56-80岁);两组平均随访均为13年(范围11-15年)。
- 为检测牛津膝关节评分(OKS)5分的最小临床重要差异,每组至少需68例以达到0.95的检验效能。
- 证据等级为III级,治疗性研究。
主要发现
- 术后10年OKS在55岁及以下组为18±6 vs 56岁及以上组20±8,平均差异-1.8(95%CI,-4.1至0.5;p=0.133),未达统计学显著。
- 术后10年膝关节协会膝关节评分在55岁及以下组为84±16 vs 56岁及以上组79±21,平均差异4.7(95%CI,-1.8至11.2;p=0.157),未达统计学显著。
- 术后10年SF-36躯体组分总结(PCS)在55岁及以下组为47±10 vs 56岁及以上组48±11,平均差异-0.4(95%CI,-4.0至3.2;p=0.827),未达统计学显著。
- 术后10年SF-36心理组分总结(MCS)在55岁及以下组为52±12 vs 56岁及以上组51±12,平均差异1.4(95%CI,-2.6至5.4;p=0.491),未达统计学显著。
- 至少10年随访时无全因翻修生存率两组均为0.96(95%CI,0.91-1.00),无差异。
临床怎么用
- 作者认为,经适当选择的年轻患者不应被排除在UKA潜在获益之外,尤其是在高手术量术者手中。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although patients who have undergone unicompartmental knee arthroplasty (UKA) report improvements in functional outcomes, orthopaedic surgeons tend to avoid UKA in younger patients due to implant survivorship concerns. As a result, few studies specifically have examined the outcomes of patients 55 years and younger. QUESTIONS/PURPOSES: Is there a difference between two cohorts of patients: those 55 years and younger and those 56 years and older who underwent UKA in terms of: (1) functional outcomes scores, (2) quality-of-life scores, and (3) implant survivorship free from all-cause revision. METHODS: Between 2004 and 2007, 100 patients 55 years and younger underwent UKA at one institution. Of those, three (3%) died, and 13 (13%) were lost to followup before the 10-year minimum required for this study, leaving 84 patients available for propensity score matching. During that same period, 343 patients older than 56 years underwent UKA; 48 (14%) died, and 59 (17%) were lost to followup before 10 years, leaving 236 patients available in that group for potential inclusion. After propensity score matching to account for confounding preoperative variables (surgeon, patient's body mass index, and sex), the patients were divided into two groups based on age: (1) 55 years and younger, (2) 56 years and older. There were 71 patients in each group, with minimum followup of 10 years. The mean age in the group of patients 55 years and younger was 52 years (range, 45-55 years) and that of the older patients was 64 years (range, 56-80 years). The mean (range) followup in both groups was 13 years (range, 11-15 years). Patient functional outcomes, quality of life scores, and implant survivorship were assessed for both groups of patients. To detect a minimum clinically important difference of 5 points in the Oxford Knee Score (OKS), a sample size of at least 68 patients in each group would be required to achieve a power of 0.95. RESULTS: With the numbers available, there were no differences between patients 55 years and younger and those 56 years and older in terms of OKS (18 ± 6 versus 20 ± 8, mean difference -1.8; 95% CI, -4.1 to 0.5; p = 0.133) and Knee Society Knee Score (84 ± 16 versus 79 ± 21, mean difference 4.7; 95% CI, -1.8 to 11.2; p = 0.157) at 10 years postoperatively. With the numbers available, there were no differences between patients 55 years and younger and those 56 years and older in terms of the physical component summary (PCS) (47 ± 10 versus 48 ± 11, mean difference -0.4; 95% CI, -4.0 to 3.2; p = 0.827) and the mental component summary (MCS) (52 ± 12 versus 51 ± 12, mean difference 1.4; 95% CI, -2.6 to 5.4; p = 0.491) of the SF-36 at 10 years postoperatively. Finally, we found no differences with the numbers available between patients 55 years and younger and those 56 years and older in terms of survivorship free from all-cause revision at a minimum of 10 years followup (both groups had the same 10-year revision-free rate of 0.96; 95% CI, 0.91-1.00). CONCLUSIONS: Because we found few differences between patients 55 years and younger and those older than that in terms of functional outcomes, quality of life, and implant survivorship after UKA, we believe that appropriately selected younger patients should not be excluded from the potential benefits of undergoing UKA, especially in the hands of high-volume surgeons. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Lee M, Chen J, Shi Lu C, et al. No Differences in Outcomes Scores or Survivorship of Unicompartmental Knee Arthroplasty Between Patients Younger or Older than 55 Years of Age at Minimum 10-Year Followup. Clin Orthop Relat Res. 2019. PMID: 31094840. doi:10.1097/CORR.0000000000000737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。